OpenVSafe by OpenVAERS
Search V-safe

7PS-25026-32430

4 vaccinations 9 coded responses 23 check-ins 8 free-text entries 2 call cases
Sex
Female
Age at first dose
66+
ZIP prefix
209 / MD
Registered
2021-03-24
Relationship
Self
Race
Black or African American
Ethnicity
Not Hispanic or Latino

Possible VAERS report

VAERS IDConfidenceScoreRunner-upShared symptomsDose StateVAERS vaccinated / onset / receivedCall case
2612989 (opens in a new window) high 11 / 11 1 7 of 11 VAERS symptoms same dose (4) MD matches 2022-10-05 / 2023-01-15 / 2023-04-11
received the same day as the last call
case 476213

From the VAERS matching of call center cases (loader/vaers_match_*). Only the best match is shown, and only if it scores 8 or more out of 11. The score adds up timing (VAERS received soon after the call center contact), dose and shared symptoms; state only breaks ties. Confidence is high when the score is 8+ and at least 3 points ahead of the runner-up, medium when 5+ and 2 ahead, otherwise low. A match is a likely link, not a confirmed one.

Timeline

  1. 2021-02-20
    Dose 1 — Moderna
  2. 2021-03-20
    Dose 2 — Moderna
  3. 2021-03-24
    Registered in v-safe
  4. 2021-03-24
    Survey response — days 1–6 daily, dose 2
    MedDRA: Ageusia, Cough, Depression, Dyspnoea, Feeling abnormal, Oropharyngeal pain, Vision blurred — Feeling: Poor · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea, Diarrhea
    Free text: coughing, shortness of breath, fuzzy brain, depression, no taste, sore throat, vision blurred
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  5. 2021-03-25
    Survey response — days 1–6 daily, dose 2
    MedDRA: Cough, Feeling abnormal, Vision blurred — Feeling: Poor · Site: Pain · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: coughing, brain fog, blurry vision
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  6. 2021-03-26
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tiredness, Nausea
    Adult check-in
  7. 2021-03-27
    Survey response — day 7, dose 2
    MedDRA: Cough — Feeling: Good · Fatigue or tiredness, Nausea
    Free text: mild coughing
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  8. 2021-04-05
    Health check-in — day 14, dose 2
    Feeling: Good
    Adult check-in
  9. 2021-04-11
    Health check-in — day 21, dose 2
    Feeling: Good
    Adult check-in
  10. 2021-04-17
    Health check-in — day 28, dose 2
    Feeling: Good
    Adult check-in
  11. 2021-04-24
    Health check-in — day 35, dose 2
    Feeling: Fair
    Adult check-in
  12. 2021-05-01
    Health check-in — day 42, dose 2
    Feeling: Good
    Adult check-in
  13. 2022-03-17
    Dose 3 — Moderna
  14. 2022-04-29
    Survey response — day 42, dose 3
    MedDRA: SARS-CoV-2 test positive — Feeling: Poor · Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit
    Free text: COVID infection with positive home test, 2/20/2022 - 3/8/2022 COVID infection with positive home test, 4/25/2022 - present
    MedDRA releases: 2024-11 · check-in free text available
  15. 2022-04-29
    Report sent to call center — day 42, dose 3
    Get care from a doctor or other healthcare professional
    Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · 1 call case(s)
  16. 2022-05-03
  17. 2022-06-20
    Survey response — 3 months, dose 3
    MedDRA: Ageusia, Brain fog, Chills, Constipation, Cough, Decreased appetite, Diarrhoea, Dizziness, Fatigue, Headache, Nausea, Oropharyngeal pain, Pain, Pyrexia, Rhinorrhoea — Feeling: Poor · Be unable to do your normal daily activities
    Free text: Runny nose, headache, fever, chills, diarrhea/constipation, nausea, achiness, dizziness (moderate to severe), tiredness, loss of taste/appetite, sore throat, coughing, memory fog
    MedDRA releases: 2024-11 · check-in free text available
  18. 2022-10-05
    Dose 4 — Moderna
  19. 2022-10-07
    Health check-in — days 1–6 daily, dose 4
    Feeling: Fair · Site: Pain · Headache, Joint pains, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school
    Adult check-in
  20. 2022-10-08
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain · Headache, Joint pains, Fatigue or tiredness
    Adult check-in
  21. 2022-10-09
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain · Muscle or body aches, Fatigue or tiredness
    Adult check-in
  22. 2022-10-10
    Health check-in — days 1–6 daily, dose 4
    Feeling: Good · Site: Pain · Fatigue or tiredness · Be unable to do your normal daily activities
    Adult check-in
  23. 2022-10-11
    Survey response — days 1–6 daily, dose 4
    MedDRA: Anxiety — Feeling: Fair · Headache, Muscle or body aches, Fatigue or tiredness · Be unable to work or attend school
    Free text: Anxiety
    MedDRA releases: 2024-11 · check-in free text available
  24. 2022-10-12
    Survey response — day 7, dose 4
    MedDRA: Anxiety — Feeling: Fair · Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to work or attend school
    Free text: Anxiety
    MedDRA releases: 2024-11 · check-in free text available
  25. 2022-10-19
    Health check-in — day 14, dose 4
    Feeling: Good
    Adult check-in
  26. 2022-10-29
    Survey response — day 21, dose 4
    MedDRA: Chills, Cough, Headache, Influenza, Nasopharyngitis, Nausea, Pain, Sneezing — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities
    Free text: Severe cold/flu symptoms. Chills. Nausea. Aching. Sneezing, coughing. Headache
    MedDRA releases: 2024-11 · check-in free text available
  27. 2022-11-02
    Health check-in — day 28, dose 4
    Feeling: Good
    Adult check-in
  28. 2022-11-09
    Health check-in — day 35, dose 4
    Feeling: Good
    Adult check-in
  29. 2023-01-06
    Health check-in — 3 months, dose 4
    Feeling: Good
    Adult check-in
  30. 2023-04-07
    Survey response — 6 months, dose 4
    MedDRA: Adenovirus infection, Asthma, Blood glucose increased, Blood pressure increased, Cough, Dyspnoea, Headache, Hospitalisation, Pre-existing disease, Rehabilitation therapy — Feeling: Fair · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Telehealth, virtual health, or email health consultation, Emergency room or emergency department visit, Hospitalization
    MedDRA releases: 2024-11
  31. 2023-04-07
    Report sent to call center — 6 months, dose 4
    Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr
    Telehealth, virtual health, or email health consultation · Emergency room or emergency department visit · Hospitalization · 1 call case(s)
  32. 2023-04-11
    Call successful
    Completed over the phone
  33. 2023-04-11
    Call successful
    Completed over the phone

Vaccinations

DoseDateManufacturerCo-administered
12021-02-20Moderna
22021-03-20Moderna
32022-03-17Moderna No
42022-10-05Moderna No

Call center

2 call center cases

2 successful

VAERS report filed, before or during a call: 2

See the call center timeline

Free text

Release 6 — days 1–6 daily, dose 2

2021-03-24

Systemic reaction (other): coughing, shortness of breath, fuzzy brain, depression, no taste, sore throat, vision blurred

2021-03-25

Systemic reaction (other): coughing, brain fog, blurry vision

Release 6 — day 7, dose 2

2021-03-27

Systemic reaction (other): mild coughing

Release 11 — day 42, dose 3

2022-04-29

Symptoms: COVID infection with positive home test, 2/20/2022 - 3/8/2022 COVID infection with positive home test, 4/25/2022 - present

Release 12 — 3 months, dose 3

2022-06-20

Symptoms: Runny nose, headache, fever, chills, diarrhea/constipation, nausea, achiness, dizziness (moderate to severe), tiredness, loss of taste/appetite, sore throat, coughing, memory fog

Release 12 — days 1–6 daily, dose 4

2022-10-11

Systemic reaction (other): Anxiety

Release 12 — day 7, dose 4

2022-10-12

Systemic reaction (other): Anxiety

Release 12 — day 21, dose 4

2022-10-29

Symptoms: Severe cold/flu symptoms. Chills. Nausea. Aching. Sneezing, coughing. Headache

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
HCVOHospitalisation · · ✓
HCVORehabilitation therapy · · ✓
SDAdenovirus infection · · ✓
SDAgeusia · · ✓
SDAsthma · · ✓
SDBlood glucose increased · · ✓
SDBlood pressure increased · · ✓
SDBrain fog · · ✓
SDChills · · ✓
SDConstipation · · ✓
SDCough · · ✓
SDDecreased appetite · · ✓
SDDiarrhoea · · ✓
SDDizziness · · ✓
SDDyspnoea · · ✓
SDFatigue · · ✓
SDHeadache · · ✓
SDInfluenza · · ✓
SDNasopharyngitis · · ✓
SDNausea · · ✓
SDOropharyngeal pain · · ✓
SDPain · · ✓
SDPre-existing disease · · ✓
SDPyrexia · · ✓
SDRhinorrhoea · · ✓
SDSARS-CoV-2 test positive · · ✓
SDSneezing · · ✓
SROAgeusia ✓ ✓ ✓
SROAnxiety · · ✓
SROCough ✓ ✓ ✓
SRODepression ✓ ✓ ✓
SRODyspnoea ✓ ✓ ✓
SROFeeling abnormal ✓ ✓ ✓
SROOropharyngeal pain ✓ ✓ ✓
SROVision blurred ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release